NCCN 2013 Biomarkers Congress Webinar Series: Selecting the Methodologies to Get the Information You Need

June 11, 2013

Biomarkers now play a key role in the routine management of patients with cancer and guide drug development in the age of targeted therapy. This webinar series will address the demand for reliable, practical information about biomarkers and their appropriate use, biomarker testing, application of test results, and clinical utility of biomarkers.

Target Audience

This educational program is designed to meet the educational needs of oncologists, pathologists, nurses, pharmacists, and other health care professionals who manage patients with cancer.

Learning Objectives

Following this activity, participants should be able to:

  • Describe the importance of pathologic expertise, internal quality control standards, and external quality assurance monitoring in determining the reliability of tumor marker testing
  • Describe the complementary roles played by pathologists and clinicians in ensuring accurate testing of tumor markers
  • List important considerations for choosing appropriate testing technology
Additional information

This activity is supported by educational grants from Abbott; Astellas Scientific and Medical Affairs, Inc.; Genentech; Novartis Pharmaceuticals Corporation; and Veridex, LLC.

Course summary
Available credit: 
  • 1.00 Participation
  • 1.00 Nurse
  • 1.00 Pharmacist
  • 1.00 Physician
Course opens: 
Course expires: 
Event starts: 
06/11/2013 - 1:00pm EDT
Event ends: 
06/11/2013 - 2:00pm EDT

Maria E. Arcila, MD
Memorial Sloan-Kettering Cancer Center

Available Credit

  • 1.00 Participation
  • 1.00 Nurse
  • 1.00 Pharmacist
  • 1.00 Physician


Please login or register to take this course.

Required Hardware/software

To complete this activity, users will need:

  • A device with an Internet connection and sound playback capability
  • Adobe Reader or other PDF reader software for certificate viewing/printing